Study on PET Imaging in Gaucher Disease and Parkinsonism Launched
A new clinical trial is investigating dopamine usage in individuals with Gaucher disease and parkinsonism using PET imaging.
Indication
Clinical and regulatory intelligence for Gaucher Disease and Parkinsonism with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.